Insulin Glargine "All to Target" Trial
NCT00384085
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
588
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Insulin Glulisine
DRUG:
Insulin Glargine
DRUG:
Premixed Insulin
DRUG:
Insulin Glulisine
Sponsor
Sanofi